Kala Bio Inc (KALA)

Jan 17, 2025

Ramesh Lal Kala , IND candidate bio : Assets , Total Income , Liabilities , Criminal Cases and other details. - The Hindu

Jan 17, 2025

Jan 10, 2025

KALA BIO Announces $10.75 Million Private Placement Agreement - WilmerHale

Jan 10, 2025

Jan 08, 2025

Kala Bio executive Todd Bazemore sells $15,206 in stock By Investing.com - Investing.com Australia

Jan 08, 2025

Jan 07, 2025

Kala Bio's head of research sells $18,662 in stock - Investing.com India

Jan 07, 2025

Jan 07, 2025

Kala Bio CEO Mark Iwicki sells $44,093 in stock - Investing.com India

Jan 07, 2025

Jan 07, 2025

Kala Bio's chief business officer sells $15,420 in stock By Investing.com - Investing.com South Africa

Jan 07, 2025

Jan 07, 2025

Kala Bio’s chief business officer sells $15,420 in stock By Investing.com - Investing.com Nigeria

Jan 07, 2025

Jan 07, 2025

Kala Bio's head of research sells $18,662 in stock By Investing.com - Investing.com South Africa

Jan 07, 2025

Jan 07, 2025

Kala Bio CFO Mary Reumuth sells $13,016 in company stock By Investing.com - Investing.com Nigeria

Jan 07, 2025

Jan 07, 2025

Kala Bio CFO Mary Reumuth sells $13,016 in company stock - Investing.com

Jan 07, 2025

Jan 07, 2025

Kala Bio's chief business officer sells $15,420 in stock - Investing.com

Jan 07, 2025

Jan 03, 2025

Baker Bros. Advisors LP Increases Stake in Kala Bio Inc - GuruFocus.com

Jan 03, 2025

Dec 31, 2024

KALA BIO announces $10.75M private placement - MSN

Dec 31, 2024

Dec 31, 2024

Baker Bros. Advisors buys $2 million in Kala Bio shares By Investing.com - Investing.com Nigeria

Dec 31, 2024

Dec 31, 2024

Baker Bros. Advisors buys $2 million in Kala Bio shares - Investing.com

Dec 31, 2024

Dec 31, 2024

KALA BIO Announces Private Placement Agreement with Institutional Investors - Defense World

Dec 31, 2024

Dec 31, 2024

Kala Bio raises $10.75 million in private placement By Investing.com - Investing.com Canada

Dec 31, 2024

Dec 30, 2024

KALA BIO Secures $10.75 Million in Private Placement to Advance Eye Disease Treatments - Tandav Media

Dec 30, 2024

Dec 30, 2024

Kala Bio raises $10.75 million in private placement - Investing.com India

Dec 30, 2024

Dec 30, 2024

KALA Bio Secures $10.75 Million for Eye Disease Treatments: What’s Next for the Biopharma Stock? - Tandav Media

Dec 30, 2024

Dec 30, 2024

KALA BIO Announces $10,750,000 Private Placement - GlobeNewswire

Dec 30, 2024

Dec 30, 2024

Global Engine Group Holding Limited Acquires 22.5% Stake in Corpotech Holdings Limited, a Hong Kong Data Centre Operator - The Manila Times

Dec 30, 2024

Dec 30, 2024

KALA BIO Secures $10.75M Investment from Major Funds, Extends Cash Runway for Key Eye Treatment Trial - StockTitan

Dec 30, 2024

Dec 27, 2024

Exicure joins hands with GPCR Therapeutics for growth in biotech (NASDAQ:XCUR) - Seeking Alpha

Dec 27, 2024

Dec 20, 2024

RBC Capital Downgrades HOOKIPA Pharma (HOOK) - MSN

Dec 20, 2024

Dec 16, 2024

KALA BIO (KALA) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? - Zacks Investment Research

Dec 16, 2024

Dec 11, 2024

Tracking Baker Brothers Portfolio – Q3 2024 Update - Seeking Alpha

Dec 11, 2024

Nov 30, 2024

Kala Bio (LTS:0JQ2) EV-to-Revenue : (As of Nov. 30, 2024) - GuruFocus.com

Nov 30, 2024

Nov 27, 2024

KALAKALA BIO, Inc. Latest Stock News & Market Updates - StockTitan

Nov 27, 2024

Nov 27, 2024

FTC Solar Announces Reverse Stock Split - The Manila Times

Nov 27, 2024

Nov 27, 2024

KALA BIO to Present at Piper Sandler Healthcare Conference, Showcasing Eye Disease Pipeline | KALA Stock News - StockTitan

Nov 27, 2024

Nov 27, 2024

KALA BIO to Present at Piper Sandler 36th Annual Healthcare Conference - GlobeNewswire

Nov 27, 2024

Nov 25, 2024

2024 Pharmaceutical Executive APEX Award Winners - Pharmaceutical Executive

Nov 25, 2024

Nov 24, 2024

Kala Pharmaceuticals Announces IND Submission of its MPP-Formulated Loteprednol Etonbonate (LE-MPP) for Post-Cataract Surgery - Marketscreener.com

Nov 24, 2024

Nov 19, 2024

Kala Pharmaceuticals retains stock target with Buy rating on trial progress - Investing.com India

Nov 19, 2024

Nov 19, 2024

60 Degrees Pharmaceuticals’ (SXTP) Neutral Rating Reaffirmed at HC Wainwright - Defense World

Nov 19, 2024

Nov 19, 2024

Walt Disney (NYSE:DIS) Price Target Raised to $130.00 - Defense World

Nov 19, 2024

Nov 19, 2024

KALA BIO’s (KALA) Buy Rating Reaffirmed at HC Wainwright - Defense World

Nov 19, 2024

Nov 15, 2024

ADAR1 Capital Management, LLC Increases Stake in Kala Bio Inc - GuruFocus.com

Nov 15, 2024

Nov 13, 2024

KALA BIO, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 13, 2024

Nov 13, 2024

Kala Bio Advances PCED Treatment Amid Financial Update - TipRanks

Nov 13, 2024

Nov 12, 2024

KALA BIO: Q3 Earnings Snapshot - mySA

Nov 12, 2024

Nov 12, 2024

KALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Nov 12, 2024

Nov 12, 2024

KALA BIO Reports $49.2M Cash Position, Advances Phase 2b PCED Trial Despite Wider Losses | KALA Stock News - StockTitan

Nov 12, 2024

Nov 06, 2024

Super Micro slumps as weak forecast, annual report uncertainty fuel investor angst - AOL

Nov 06, 2024

Nov 05, 2024

ENEVA S A/S (OTCMKTS:ENEVY) Shares Down 10.7% – Here’s What Happened - Defense World

Nov 05, 2024